Skip to main content
. Author manuscript; available in PMC: 2013 Jun 25.
Published in final edited form as: Stroke. 2009 Mar 12;40(5):1827–1833. doi: 10.1161/STROKEAHA.108.536805

Figure 3.

Figure 3

Effects of BH4 (1 mmol/L), a nitric oxide synthase cofactor; DT-3, a protein kinase G inhibitor (25 nmol/L), and ODQ, a soluble guanylate cyclase inhibitor (1 μmol/L), on (A–B) flow-mediated dilation and (C) changes in fluorescence intensities induced by flow (10 μL/min) in pressurized mouse cerebral arteries loaded with DCF-DA (5 μmol/L; “n” numbers are reported in the Table). *P<0.05 compared with control.